Cell Transplantation (Mar 2024)

Cross Talk Between Cells and the Current Bioceramics in Bone Regeneration: A Comprehensive Review

  • Danial Khayatan,
  • Asal Bagherzadeh Oskouei,
  • Mostafa Alam,
  • Meysam Mohammadikhah,
  • Ashkan Badkoobeh,
  • Mohsen Golkar,
  • Kamyar Abbasi,
  • Shahryar Karami,
  • Reza Sayyad Soufdoost,
  • Lotfollah Kamali Hakim,
  • Ahmed Hussain,
  • Hamid Tebyaniyan,
  • Artak Heboyan

DOI
https://doi.org/10.1177/09636897241236030
Journal volume & issue
Vol. 33

Abstract

Read online

The conventional approach for addressing bone defects and stubborn non-unions typically involves the use of autogenous bone grafts. Nevertheless, obtaining these grafts can be challenging, and the procedure can lead to significant morbidity. Three primary treatment strategies for managing bone defects and non-unions prove resistant to conventional treatments: synthetic bone graft substitutes (BGS), a combination of BGS with bioactive molecules, and the use of BGS in conjunction with stem cells. In the realm of synthetic BGS, a multitude of biomaterials have emerged for creating scaffolds in bone tissue engineering (TE). These materials encompass biometals like titanium, iron, magnesium, and zinc, as well as bioceramics such as hydroxyapatite (HA) and tricalcium phosphate (TCP). Bone TE scaffolds serve as temporary implants, fostering tissue ingrowth and the regeneration of new bone. They are meticulously designed to enhance bone healing by optimizing geometric, mechanical, and biological properties. These scaffolds undergo continual remodeling facilitated by bone cells like osteoblasts and osteoclasts. Through various signaling pathways, stem cells and bone cells work together to regulate bone regeneration when a portion of bone is damaged or deformed. By targeting signaling pathways, bone TE can improve bone defects through effective therapies. This review provided insights into the interplay between cells and the current state of bioceramics in the context of bone regeneration.